Global Theranostics Market Research Report: Forecast (2024-2030)

Name: Global Theranostics Market Research Report: Forecast (2024-2030)
Creator: MarkNtel Advisors
License: https://www.marknteladvisors.com/privacy-policy

Theranostics Market - By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarkers Screening, Software & Services), By Application (Prostate Cancer, Neuroendocrine Cancer, ...Adult Pheochromocytoma, Others), By End Users (Hospitals, Diagnostic Centers) and others Read more

Healthcare
May 2024
Pages 199
Report Format: PDF, Excel, PPT

Get Actionable Insights for Smarter Decisions: Regional and country reports in one place pick a location for insights and Trends.

Market Definition

Theranostics is an integrated approach combining diagnostic and therapeutic capabilities within a single platform, enabling personalized medicine strategies. It involves the use of diagnostic techniques to identify biomarkers or molecular targets associated with specific diseases, guiding the selection of targeted therapies tailored to individual patients.

Market Insights & Analysis: Global Theranostics Market (2024-30):

The Global Theranostics Market size is estimated to grow at a CAGR of around 14.4% during the forecast period, i.e., 2024-30. The market for theranostics has been growing at a significant rate during the past few years, owing to several key factors. The increasing number of hospitals, along with a growing emphasis on targeted therapies, has been contributing to this market expansion. Moreover, the introduction of innovative theranostics approaches in recent years has further escalated market growth & development.

Report Coverage	Details
Study Period	Historical Data: 2019-22
	Base Year: 2023
	Forecast Period: 2024-30
CAGR (2024-2030)	14.4%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
	South America: Brazil, Argentina, Rest of South America
	Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA
Key Companies Profiled	Siemens Healthcare Private Limited, GE HealthCare, Bayer AG, Cardinal Health, Hologic, Inc., Radiopharm Theranostics Limited, ITM Isotope Technologies Munich SE, Isotopia Molecular Imaging, Perspective Therapeutics, Ratio Therapeutics, ChiRhoClin, Cerebral, Therapeutics, Inc., Telix Pharmaceuticals Limited, Biosynth Ltd., Theradiag, Others
Unit Denominations	USD Million/Billion

Additionally, a significant contributor to market growth has been the integration of artificial intelligence (AI) in diagnostics, which has been enhancing its accuracy and efficiency. Furthermore, recent FDA approvals have heightened awareness and bolstered the adoption of theranostics, paving the way for personalized medicine practices. Personalized medicine is an innovative approach that ensures that treatments are optimized based on the unique molecular and cellular profiles of each patient, leading to improved outcomes and reduced side effects. Thus, theranostics, by combining diagnostics and therapy, has enabled individualized and targeted treatment strategies. Also, in the realm of cancer management, theranostics and precision medicine have played pivotal roles, allowing healthcare professionals to identify specific biomarkers and tailor treatments accordingly, thereby increasing treatment success rates.

Further, developing countries, such as India and China, present significant growth opportunities for market players despite cost concerns. The sizable population base in these regions offers a sustainable market for theranostics, driven by the pressing need for early detection and management of chronic diseases like cancer, strokes, and cardiovascular diseases. Hence, as companies in the theranostics market are making efforts to expand across developing countries, it would help in the overall market growth during the forecast period.

Theranostics Market Share, Size, & Growth Forecast | Global Trends By 2030

Global Theranostics Market Driver:

Rising Collaborations to Improve Patient Care in the Global Theranostics Market – The increasing emphasis on collaborations among companies to enhance patient care in theranostics has been propelling the growth of the Global Theranostics Market. The collaborations have been focused on bolstering research, clinical collaboration, and educational programs in theranostics, which integrate diagnoses and targeted treatments to optimize disease diagnosis and treatment monitoring. Also, through collaborations, companies aim to increase awareness among consumers and healthcare professionals regarding the benefits and effectiveness of theranostics. These partnerships have been spurred by the escalating demand for theranostics practices, particularly following the approval of new theranostics-related drugs and therapies by organizations like Health Canada and the U.S. Food and Drug Administration. For instance,

In 2023, GE HealthCare partnered with St. Joseph's Health Care London and the Lawson Health Research Institute to establish a Theranostics Center of Excellence. This center aims to bolster research endeavors, foster clinical partnerships, and develop educational initiatives to advance the field of theranostics. Its mission is to enhance awareness, education, training, and patient care accessibility in this evolving practice.

These alliances are an indication of the growing recognition of theranostics as a pivotal approach in modern healthcare, blending therapy and diagnostics to optimize disease management.

Additionally, theranostics involves the integration of molecular imaging technologies and advanced digital solutions for personalized therapy. Thus, some collaborations seek to enhance production and access to radioisotopes, advance technologies for improved image quality and care coordination, and educate healthcare practitioners and government bodies to bolster theranostic adoption and advancement. Ultimately, the goal is to ensure the right patients receive the right treatments at the right time, leading to enhanced patient outcomes. Thus, as awareness improves, more healthcare professionals prefer this modality. Ultimately, it would augment the size & volume of the theranostics industry over the forecast period.

Global Theranostics Market Opportunity:

Increasing Demand for Personalized Medicine Offers Lucrative Growth Opportunities – An increasingly prominent opportunity for the Global Theranostics Market lies in the expanding demand for personalized medicine in recent years. Propelled by notable advancements in molecular diagnostics and targeted therapies, personalized medicine offers tailored treatments that precisely match individual patients' unique biological characteristics and disease profiles. Hence, as theranostics integrates therapy and diagnostics to enable precise identification of molecular targets, particularly in diseases like tumors, its demand is projected to escalate with increasing demand for personalized medicines.

Further, by facilitating the selection of therapies optimized for each patient, theranostics enhances treatment efficacy and also minimizes unnecessary interventions, improves disease monitoring, and potentially reduces overall healthcare costs. Thus, with the healthcare landscape inclining towards tailored approaches, the demand for theranostics would amplify, which underscores a significant growth opportunity for the market in the coming years.

Global Theranostics Market Challenge:

Lack of Properly Defined Regulations for Theranostics Tests to Hinder Market Growth & Expansion – A significant challenge for the Global Theranostics Market lies in the absence of well-defined and harmonized regulatory frameworks governing theranostic testing procedures, validation standards, and quality benchmarks. The lack of clarity and consistency in regulatory guidelines has been introducing uncertainty and slowing down the development and commercialization of cutting-edge theranostic technologies. Further, as this technology is new, a lack of regulation has been leading to a longer approval process, leading to delays in market entry and impeding the timely delivery of innovative diagnostic and therapeutic solutions to patients. Thus, it has further led to a negative impact on the overall revenue growth of the market in recent years.

Additionally, navigating through disparate international regulatory landscapes presents considerable challenges for businesses. Under this, companies need to follow up and comply with all the regulations introduced by healthcare organizations in different regions and countries, which has emerged to be quite hectic. Thus, it has been further exacerbating delays and hindering the overall growth potential of the theranostics industry.

Global Theranostics Market Trend:

Companion Diagnostics Gaining Momentum in the Theranostics Industry – Companion diagnostics have emerged as a crucial market trend within the field of theranostics, representing a pivotal advancement in personalized medicine. Developed alongside specific therapies, these diagnostics play a multifaceted role in guiding treatment decisions, monitoring therapeutic responses, and predicting potential adverse effects. By leveraging molecular insights to identify patients who are most likely to benefit from particular treatments, companion diagnostics have been empowering healthcare providers to deliver targeted interventions, thereby optimizing treatment efficacy and enhancing patient outcomes. Hence, the adoption of companion diagnostics has emerged as a recent trend in the Global Theranostics Market.

Additionally, as the healthcare industry increasingly embraces the principles of precision medicine, the demand for companion diagnostics within the theranostics market is expected to witness substantial growth. This expansion would be driven by a growing recognition of the value that companion diagnostics bring to therapeutic decision-making, enabling clinicians to tailor treatments to individual patient profiles with unprecedented precision. Moreover, the integration of companion diagnostics into Theranostics protocols facilitates more effective treatment strategies and also highlights the transformative potential of personalized medicine in revolutionizing healthcare delivery and improving patient care on a global scale.

Global Theranostics Market (2024-30): Segmentation Analysis

The Global Theranostics Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2024–2030 at the global level. According to the analysis, the market has been further classified as:

Based on the Product

Diagnostic Imaging
- MRI
- Pet Imaging
- Nuclear Imaging
- Others (CT Scan, Molecular Imaging, etc.)
Radiopharmaceuticals
- Lutetium-177
- Samarium-153
- Radium-223
- Iodine-131
- Yttrium-90
- Others (Gallium-68, Fluorine-18, etc.)
IVD/Biomarkers Screening
- Polymerase Chain Reaction
- Next-Generation Sequencing (NGS)
- Fluorescence in-situ Hybridization (FISH)
Software & Services

Among these, the polymerase chain reaction (PCR) segment has experienced rapid growth, with a major share in the Global Theranostics Market. This growth trajectory has been fueled by several factors, notably the escalating demand for swift and precise diagnostic tests across various medical domains. PCR's versatility and accuracy make it a cornerstone for diagnosing a wide array of diseases, from infectious illnesses to genetic disorders. Additionally, the continuous advancements in PCR-based technologies, including digital PCR and droplet digital PCR, are revolutionizing diagnostic capabilities. These innovations not only enhance the sensitivity and specificity of PCR assays but also enable high-throughput testing, paving the way for more efficient and comprehensive disease detection and monitoring. As healthcare systems worldwide prioritize early diagnosis and personalized treatment strategies, the PCR segment is expected to play an increasingly pivotal role in driving innovation and shaping the future of the theranostics industry.

By End Users

Hospitals
Diagnostic Centers
Others (Research Institutes and Academic Centers, Specialty Clinics, etc.)

Hospitals have emerged as a leading segment in the Global Theranostics Market. This segment holds a major market share. This surge has been supported by a multitude of factors, foremost among them being the escalating number of patients seeking theranostic diagnosis and treatment. As the prevalence of chronic diseases continues to soar globally, there has been an ever-increasing demand for targeted diagnostic and therapeutic solutions that cater to the needs of each patient. This demand has been further fueled by the growing demand for precision medicine, where healthcare providers strive to deliver tailored treatment regimens based on individual genetic makeup, disease characteristics, and treatment responses. Consequently, hospitals have been increasingly adopting theranostic technologies as integral components of their diagnostic and treatment processes, thus catalyzing the rapid expansion of this segment.

Further, in recent years, hospitals have been experiencing a significant expansion, driven by governmental policies and initiatives across different countries. Also, most patients consider hospitals as their first choice for seeking any disease-related consultations. Therefore, it is anticipated to be dominant in the theranostics market in the forthcoming years as well.

Global Theranostics Market (2024-30): Regional Projections

Geographically, the Global Theranostics Market expands across:

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

North America has been experiencing substantial growth in the Global Theranostics Market throughout the historical period. This has been driven by the escalating demand for enhanced and personalized treatment options, particularly due to the rising incidence of cancer cases across the region. As cancer diagnoses become more prevalent in North America, there has been an urgent need for more effective and tailored therapeutic approaches, and theranostics emerges as a pivotal solution. By leveraging advanced diagnostic techniques to identify specific biomarkers associated with various cancers, theranostics enables clinicians to deliver targeted therapies precisely tailored to each patient's unique molecular profile.

Moreover, the growing popularity of personalized medicine techniques further bolsters the demand for theranostics in North America. With personalized medicine gaining traction, the focus is shifting towards customizing treatment regimens based on individual genetic compositions, disease characteristics, and biomarker profiles. Theranostics plays a central role in this paradigm shift by providing clinicians with invaluable insights into the molecular mechanisms driving disease progression, thereby facilitating the development of highly personalized treatment strategies. This convergence of advanced diagnostics, targeted therapies, and personalized medicine principles highlights the crucial role of theranostics in reshaping the landscape of cancer care in North America. As such, the region is poised to maintain its dominance in the theranostics industry, driven by the pressing need for more precise and tailored treatment options amidst the rising burden of cancer cases.

Global Theranostics Industry Recent Development:

In 2023: GE HealthCare and Mayo Clinic announced a strategic healthcare collaboration to innovate medical imaging and theranostics, involving scientists, clinicians, and technology developers from both entities. The collaboration aims to enhance clinicians' diagnostic and treatment capabilities while personalizing patient experiences through the translation of novel technologies into clinical practice.

Gain a Competitive Edge with Our Global Theranostics Market Report

Global Theranostics Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of market dynamics & make informed decisions.
This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
Global Theranostics Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

A. The Theranostics Market is expected to grow at a compound annual growth rate (CAGR) of around 14.4% over the forecast period.

A. The rising collaborations to improve patient care is expected to drive the Theranostics Market during 2024-30.

A. Siemens Healthcare Private Limited, GE HealthCare, Bayer AG, Cardinal Health, Hologic, Inc., Radiopharm Theranostics Limited, ITM Isotope Technologies Munich SE, Isotopia Molecular Imaging, Perspective Therapeutics, Ratio Therapeutics, ChiRhoClin, Cerebral Therapeutics, Inc., Telix Pharmaceuticals Limited, Biosynth Ltd., Theradiag, and others are the major companies operating in the Theranostics Market.

A. The polymerase chain reaction (PCR) segment held the largest share of the Theranostics Market.

A. North America would present growth prospects in the Theranostics Market during 2024-30.

A. The increasing popularity of companion diagnostics is a key trend shaping the growth of the Theranostics Market.

A. The increasing demand for personalized medicine is one of the growing opportunities driving the Theranostics Market.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Theranostics Market Patent Analysis
Global Theranostics Market Clinical Trial Analysis
Global Theranostics Market Trends & Insights
Global Theranostics Market Dynamics
1. Drivers
2. Challenges
Global Theranostics Market Hotspots & Opportunities
Global Theranostics Market Supply Chain Analysis
Global Theranostics Market Regulations & Policies
Global Theranostics Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product
    1. Diagnostic Imaging- Market Size & Forecast 2019-2030F, USD Million
      1. MRI- Market Size & Forecast 2019-2030F, USD Million
      2. Pet Imaging- Market Size & Forecast 2019-2030F, USD Million
      3. Nuclear Imaging- Market Size & Forecast 2019-2030F, USD Million
      4. Others (CT Scan, Molecular Imaging, etc.)- Market Size & Forecast 2019-2030F, USD Million
    2. Radiopharmaceuticals- Market Size & Forecast 2019-2030F, USD Million
      1. Lutetium-177- Market Size & Forecast 2019-2030F, USD Million
      2. Samarium-153- Market Size & Forecast 2019-2030F, USD Million
      3. Radium-223- Market Size & Forecast 2019-2030F, USD Million
      4. Iodine-131- Market Size & Forecast 2019-2030F, USD Million
      5. Yttrium-90- Market Size & Forecast 2019-2030F, USD Million
      6. Others (Gallium-68 Fluorine-18, etc.) - Market Size & Forecast 2019-2030F, USD Million
    3. IVD/Biomarkers Screening- Market Size & Forecast 2019-2030F, USD Million
      1. Polymerase Chain Reaction- Market Size & Forecast 2019-2030F, USD Million
      2. Next-Generation Sequencing (NGS)- Market Size & Forecast 2019-2030F, USD Million
      3. Fluorescence in-situ Hybridization (FISH)- Market Size & Forecast 2019-2030F, USD Million
    4. Software & Services- Market Size & Forecast 2019-2030F, USD Million
  2. By Application
    1. Prostate Cancer- Market Size & Forecast 2019-2030F, USD Million
    2. Neuroendocrine Cancer- Market Size & Forecast 2019-2030F, USD Million
    3. Adult Pheochromocytoma- Market Size & Forecast 2019-2030F, USD Million
    4. Others (Paraganglioma, Pediatric Neuroblastoma, etc.)- Market Size & Forecast 2019-2030F, USD Million
  3. By End Users
    1. Hospitals- Market Size & Forecast 2019-2030F, USD Million
    2. Diagnostic Centers- Market Size & Forecast 2019-2030F, USD Million
    3. Others (Research Institutes and Academic Centers, Specialty Clinics, etc.)- Market Size & Forecast 2019-2030F, USD Million
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Market Share of Top Companies
    2. Competition Characteristics
North America Theranostics Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030F, USD Million
  2. By Application- Market Size & Forecast 2019-2030F, USD Million
  3. By End Users- Market Size & Forecast 2019-2030F, USD Million
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
4. Canada Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
5. Mexico Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
South America Theranostics Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030F, USD Million
  2. By Application- Market Size & Forecast 2019-2030F, USD Million
  3. By End Users- Market Size & Forecast 2019-2030F, USD Million
  4. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
4. Argentina Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
Europe Theranostics Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030F, USD Million
  2. By Application- Market Size & Forecast 2019-2030F, USD Million
  3. By End Users- Market Size & Forecast 2019-2030F, USD Million
  4. By Country
    1. Germany
    2. The UK
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. Germany Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
4. The UK Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
5. France Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
6. Italy Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
7. Spain Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
The Middle East & Africa Theranostics Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030F, USD Million
  2. By Application- Market Size & Forecast 2019-2030F, USD Million
  3. By End Users- Market Size & Forecast 2019-2030F, USD Million
  4. By Country
    1. Saudi Arabia
    2. The UAE
    3. South Africa
    4. Rest of the Middle East & Africa
3. Saudi Arabia Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
4. The UAE Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
5. South Africa Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
Asia Pacific Theranostics Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030F, USD Million
  2. By Application- Market Size & Forecast 2019-2030F, USD Million
  3. By End Users- Market Size & Forecast 2019-2030F, USD Million
  4. By Country
    1. China
    2. Japan
    3. India
    4. South Korea
    5. Australia
    6. Rest of Asia Pacific
3. China Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
4. Japan Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
5. India Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
6. South Korea Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
7. Australia Theranostics Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030F, USD Million
    2. By End Users- Market Size & Forecast 2019-2030F, USD Million
Global Theranostics Market Key Strategic Imperatives for Growth & Success
Competition Outlook
1. Company Profiles
  1. Siemens Healthcare Private Limited
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. GE HealthCare
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Bayer AG
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Cardinal Health
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Hologic, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Radiopharm Theranostics Limited
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. ITM Isotope Technologies Munich SE
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Isotopia Molecular Imaging
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Perspective Therapeutics
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Ratio Therapeutics
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. ChiRhoClin
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Cerebral Therapeutics, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Telix Pharmaceuticals Limited
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Biosynth Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Theradiag
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying